Research Solutions Q3 ARR Growth Decelerates Sharply, Raising Concerns

What happened

Research Solutions reported fiscal Q3 2026 results with ARR of $22.1 million, growing only 8.5% year-over-year, a marked deceleration from the 21% growth in Q1. Net income came in at $860 thousand, and adjusted EBITDA rose 14% from the prior year, but these profitability metrics remain thin relative to the company's market cap. The company highlighted its AI-powered research workflow platform, but the slowing ARR suggests that recent product enhancements may not be translating into sustained high growth. Coupled with the deep value report's identified risks—including supplier concentration, large contingent earnouts, and a narrow moat—the results underscore the fragility of the growth narrative. The stock traded around $2.81, slightly below the levels analyzed in the deep value report, reflecting market disappointment.

Implication

The Q3 results reveal a sharp slowdown in ARR growth (8.5% vs 21% in Q1), undermining a key pillar of the investment case. While profitability improved, the deceleration signals possible market saturation or competitive pressure. The narrow moat and earnout liabilities add downside risk. A more cautious stance is warranted unless growth rebounds convincingly in Q4.

Thesis delta

The earlier potential buy thesis assumed sustained ~20% ARR growth, but the reported 8.5% growth in Q3 represents a clear deceleration. This increases the probability that the company is facing headwinds from open access trends or competitive pressures. The thesis shifts from cautiously constructive to more skeptical, pending evidence that growth can re-accelerate.